These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34169190)

  • 1. HLA Eplet Mismatches in Kidney Transplantation: More Than Just Adding Things Up.
    Sypek MP; Hughes P
    Kidney Int Rep; 2021 Jun; 6(6):1500-1502. PubMed ID: 34169190
    [No Abstract]   [Full Text] [Related]  

  • 2. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation.
    Do Nguyen HT; Wong G; Chapman JR; McDonald SP; Coates PT; Watson N; Russ GR; D'Orsogna L; Lim WH
    Transplant Direct; 2016 Dec; 2(12):e120. PubMed ID: 27990485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
    Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
    Front Immunol; 2022; 13():844438. PubMed ID: 35799779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
    Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
    Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T and B Cell Epitopes to Predict the Risk of
    Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
    Front Immunol; 2020; 11():2000. PubMed ID: 32973806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
    Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
    J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplet matching in pediatric heart transplantation: The SickKids experience.
    Cardoso B; Wang J; Kiernan J; Dipchand AI
    J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation and agreement between eplet mismatches calculated using serological, low-intermediate and high resolution molecular human leukocyte antigen typing methods.
    Fidler S; D'Orsogna L; Irish AB; Lewis JR; Wong G; Lim WH
    Oncotarget; 2018 Mar; 9(17):13116-13124. PubMed ID: 29568344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
    Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
    Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA B eplet mismatches in the context of delayed graft function and low tacrolimus trough levels are risk factors influencing the generation of de novo donor-specific antibodies and acute rejection in the early stage after kidney transplantation.
    Gao S; Gong H; Li M; Lan P; Zhang M; Kuang P; Zhang Y; Hu X; Ding C; Li Y; Ding X; Xue W; Zheng J
    Transpl Immunol; 2023 Dec; 81():101955. PubMed ID: 37931666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia.
    Stefańska K; Kurkowiak M; Piekarska K; Chruściel E; Zamkowska D; Jassem-Bobowicz J; Adamski P; Świątkowska-Stodulska R; Abacjew-Chmyłko A; Leszczyńska K; Zieliński M; Preis K; Zielińska H; Tymoniuk B; Trzonkowski P; Marek-Trzonkowska NM
    Front Immunol; 2023; 14():1272021. PubMed ID: 38022600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
    Bezstarosti S; Meziyerh S; Reinders MEJ; Voogt-Bakker K; Groeneweg KE; Roelen DL; Kers J; de Fijter JW; Heidt S
    HLA; 2023 Jul; 102(1):3-12. PubMed ID: 36841928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen, allele, and eplet mismatches in liver transplantation; observations from a small, single center cohort.
    Forner D; Liwski R; Alwayn I
    Hum Immunol; 2018 Mar; 79(3):154-159. PubMed ID: 29289739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients.
    Zhang J; Liu D; Zhang C; Zhou M; Lv J; Wang H; Yang H; Fan L; Wu B; Chen J
    Ann Transl Med; 2020 Feb; 8(3):37. PubMed ID: 32154282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.